0000021665False00000216652026-03-172026-03-170000021665us-gaap:CommonStockMember2026-03-172026-03-170000021665cl:A0300NotesDue2029Member2026-03-172026-03-170000021665cl:A1.375NotesDue2034Member2026-03-172026-03-170000021665cl:A3.250NotesDue2035Member2026-03-172026-03-170000021665cl:A0.875Notesdue2039Member2026-03-172026-03-17
        
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 17, 2026

COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)

Delaware
1-644
13-1815595
(State or Other Jurisdiction of Incorporation)
 (Commission File Number)
(IRS Employer Identification No.)

300 Park Avenue,
New York,NY10022
 (Address of Principal Executive Offices)
(Zip Code)
                                  


Registrant’s telephone number, including area code (212) 310-2000


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Securities 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange
on which registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.300% Notes due 2029
CL29
New York Stock Exchange
1.375% Notes due 2034
CL34
New York Stock Exchange
3.250% Notes due 2035
CL35
New York Stock Exchange
0.875% Notes due 2039
CL39
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 8.01. Other Events.

As part of the previously announced Strategic Growth and Productivity Program, to further optimize and leverage the operating scale and drive growth within the Europe and Africa/Eurasia regions, effective for the quarter ending March 31, 2026, Colgate-Palmolive Company (the “Company”) has realigned its reportable operating segments. Commencing with the Company’s financial reporting for the quarter ending March 31, 2026, the results of its Europe and Africa/Eurasia (excluding Russia and Belarus) reportable operating segments and its Skin Health business (previously within the North America reportable operating segment) will be combined to form a new Europe, Middle East and Africa reportable operating segment. In conjunction with this realignment, Russia and Belarus, which were previously reported within the Africa/Eurasia reportable operating segment, will now be reported within the Asia Pacific reportable operating segment. This reportable operating segment realignment did not impact the Company’s historical consolidated results of operations, financial position or cash flows.

For information purposes and to provide investors with historical information on a basis consistent with its new reporting structure, the Company has recast its historical geographic segment information to conform to the new reporting structure.

Attached as Exhibit 99 and incorporated by reference in this Item 8.01 are schedules containing segment information by operating segment for the years ended December 31, 2025, 2024 and 2023, the three months ended March 31, 2025, the three and six months ended June 30, 2025 and the three and nine months ended September 30, 2025.

As noted above, the segment change and supplemental disclosures discussed above have no impact on the Company’s historical consolidated results of operations, financial position or cash flows. The recast financial information contained in Exhibit 99 does not represent a restatement of the Company’s previously issued financial statements. The information in this Item 8.01, including Exhibit 99, should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.


Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits. The following exhibits are filed with this document:
        
Exhibit Number
Description
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.                            

                                               >                 
COLGATE-PALMOLIVE COMPANY
Date: March 17, 2026
By:
 /s/ Stanley J. Sutula III    
Name: Stanley J. Sutula III
Title: Chief Financial Officer



3
Exhibit 99
Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Year Ended December 31,
2025
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$3,679 $1,510 $1,375 $4 $790 
Latin America4,776 2,107 1,268 (11)1,411 
Europe, Middle East & Africa 4,276 1,572 1,686 80 938 
Asia Pacific3,038 1,137 1,101 (20)820 
Total Oral, Personal and Home Care(1)
15,769 3,959 
Pet Nutrition(2)
4,613 1,818 1,717 14 1,064 
Reconciliation with Total Company Operating Profit
Corporate(1,717)
Total $20,382 $3,306 
Note: Table may not sum due to rounding.
(1) Net sales in the United States for Oral, Personal and Home Care were $3,596 in 2025.
(2) Net sales in the United States for Pet Nutrition were $3,062 in 2025.


Year Ended December 31,
2024
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$3,716 $1,476 $1,393 $(9)$856 
Latin America4,782 1,933 1,328 (5)1,526 
Europe, Middle East & Africa4,046 1,511 1,637 85 814 
Asia Pacific3,074 1,144 1,061 (23)892 
Total Oral, Personal and Home Care(1)
15,618 4,088 
Pet Nutrition(2)
4,483 1,869 1,641 8 965 
Reconciliation with Total Company Operating Profit
Corporate(784)
Total$20,101 $4,268 
Note: Table may not sum due to rounding.
(1) Net sales in the United States for Oral, Personal and Home Care were $3,640 in 2024.
(2) Net sales in the United States for Pet Nutrition were $3,059 in 2024.









Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Year Ended December 31,
2023
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$3,665 $1,489 $1,338 $4 $834 
Latin America4,640 1,977 1,241 5 1,417 
Europe, Middle East & Africa3,822 1,537 1,460 71 754 
Asia Pacific3,041 1,182 997 (16)878 
Total Oral, Personal and Home Care(1)
15,167 3,882 
Pet Nutrition(2)
4,290 1,964 1,493 26806 
Reconciliation with Total Company Operating Profit
Corporate(704)
Total$19,457 $3,984 
Note: Table may not sum due to rounding.
(1) Net sales in the United States for Oral, Personal and Home Care were $3,625 in 2023.
(2) Net sales in the United States for Pet Nutrition were $2,918 in 2023


Years Ended December 31,
202520242023
Capital expenditures  
Oral, Personal and Home Care  
North America$63 $47 $45 
Latin America141 126 146 
Europe, Middle East & Africa75 80 55 
Asia Pacific82 64 65 
Total Oral, Personal and Home Care361 317 311 
Pet Nutrition88 143 301 
Corporate115 101 93 
Total Capital expenditures$564 $561 $705 


Years Ended December 31,
202520242023
Depreciation and amortization  
Oral, Personal and Home Care  
North America$77 $78 $79 
Latin America106 100 98 
Europe, Middle East & Africa122 119 111 
Asia Pacific80 81 84 
Total Oral, Personal and Home Care385 378 372 
Pet Nutrition144 132 101 
Corporate101 95 94 
Total Depreciation and amortization$630 $605 $567 



Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Three Months Ended March 31,
2025
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$904 $358 $350 $— $197 
Latin America1,143 487 316 (7)348 
Europe, Middle East & Africa1,007 367 399 18 222 
Asia Pacific738 275 264 (5)204 
Total Oral, Personal and Home Care3,792 971 
Pet Nutrition1,118 437 422 1 258 
Reconciliation with Total Company Operating Profit
Corporate(153)
Total $4,911 $1,076 
Note: Table may not sum due to rounding.


Three Months Ended March 31,
2025
Capital expenditures 
Oral, Personal and Home Care 
North America$16 
Latin America28 
Europe, Middle East & Africa11 
Asia Pacific13 
Total Oral, Personal and Home Care68 
Pet Nutrition21 
Corporate35 
Total Capital expenditures$124 



Three Months Ended March 31,
2025
Depreciation and amortization 
Oral, Personal and Home Care 
North America$19 
Latin America24 
Europe, Middle East & Africa29 
Asia Pacific20 
Total Oral, Personal and Home Care92 
Pet Nutrition31 
Corporate25 
Total Depreciation and amortization$148 



Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Three Months Ended June 30,
2025
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$919 $380 $349 $3 $187 
Latin America1,207 527 318 (6)367 
Europe, Middle East & Africa1,083 395 428 19 241 
Asia Pacific746 284 265 (6)202 
Total Oral, Personal and Home Care3,954 997 
Pet Nutrition1,157 462 430 — 264 
Reconciliation with Total Company Operating Profit
Corporate(181)
Total$5,110 $1,080 
Note: Table may not sum due to rounding.


Six Months Ended June 30,
2025
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$1,823 $737 $700 $3 $384 
Latin America2,350 1,014 633 (13)715 
Europe, Middle East & Africa2,089 762 827 38 463 
Asia Pacific1,484 559 529 (11)407 
Total Oral, Personal and Home Care7,746 1,968 
Pet Nutrition2,275 899 852 1 523 
Reconciliation with Total Company Operating Profit
Corporate(334)
Total$10,021 $2,156 
Note: Table may not sum due to rounding.
















Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
20252025
Capital expenditures 
Oral, Personal and Home Care 
North America$13 $29 
Latin America21 50 
Europe, Middle East & Africa15 25 
Asia Pacific19 32 
Total Oral, Personal and Home Care68 136 
Pet Nutrition22 43 
Corporate18 53 
Total Capital expenditures$108 $232 


Three Months Ended June 30,Six Months Ended June 30,
20252025
Depreciation and amortization 
Oral, Personal and Home Care 
North America$19 $38 
Latin America27 51 
Europe, Middle East & Africa30 58 
Asia Pacific19 40 
Total Oral, Personal and Home Care95 187 
Pet Nutrition31 63 
Corporate25 49 
Total Depreciation and amortization$151 $299 



Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Three Months Ended September 30,
2025
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$922 $381 $342 $(1)$199 
Latin America1,178 541 303 (2)337 
Europe, Middle East & Africa1,115 417 435 20 243 
Asia Pacific775 288 280 (6)213 
Total Oral, Personal and Home Care3,989 992 
Pet Nutrition1,142 457 427 2 255 
Reconciliation with Total Company Operating Profit
Corporate(189)
Total$5,131 $1,059 
Note: Table may not sum due to rounding.


Nine Months Ended September 30,
2025
Net salesCost of SalesSelling, general and administrative expensesOther (income) expense, netOperating Profit
Reportable Segments
Oral, Personal and Home Care
North America$2,745 $1,119 $1,042 $2 $583 
Latin America3,528 1,555 936 (15)1,052 
Europe, Middle East & Africa3,204 1,179 1,261 58 706 
Asia Pacific2,259 847 809 (17)620 
Total Oral, Personal and Home Care11,735 2,961 
Pet Nutrition3,417 1,356 1,280 4 778 
Reconciliation with Total Company Operating Profit
Corporate(523)
Total$15,152 $3,214 
Note: Table may not sum due to rounding.
















Colgate-Palmolive Company
Segment Information (Recast)
(Dollars in Millions) (Unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
20252025
Capital expenditures 
Oral, Personal and Home Care 
North America$17 $46 
Latin America46 96 
Europe, Middle East & Africa22 46 
Asia Pacific18 51 
Total Oral, Personal and Home Care103 239 
Pet Nutrition21 64 
Corporate31 84 
Total Capital expenditures$155 $387 


Three Months Ended September 30,Nine Months Ended September 30,
20252025
Depreciation and amortization 
Oral, Personal and Home Care 
North America$20 $58 
Latin America27 78 
Europe, Middle East & Africa30 89 
Asia Pacific20 59 
Total Oral, Personal and Home Care97 284 
Pet Nutrition35 98 
Corporate26 75 
Total Depreciation and amortization$158 $457